Navigation Links
Keryx Biopharmaceuticals, Inc. Announces Upcoming Poster Presentation of Zerenex (ferric citrate) for the Treatment of Hyperphosphatemia at the Upcoming American Society of Nephrology Renal Week Meeting in San Diego
Date:10/26/2009

2 clinical development for multiple tumor types, with a Phase 3 in multiple myeloma, under Special Protocol Assessment (SPA), pending commencement by year-end. Keryx is also developing Zerenex(TM) (ferric citrate), an oral, iron-based compound that has the capacity to bind to phosphate and form non-absorbable complexes. Zerenex has recently completed a Phase 2 clinical program as a treatment for hyperphosphatemia (elevated phosphate levels) in patients with end-stage renal disease, and Keryx is in the process of finalizing the U.S. Phase 3 program for Zerenex in consultation with the FDA. Keryx is headquartered in New York City.

Cautionary Statement

Some of the statements included in this press release, particularly those anticipating future clinical and business prospects for Zerenex (ferric citrate), may be forward-looking statements that involve a number of risks and uncertainties. For those statements, we claim the protection of the safe harbor for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995. Among the factors that could cause our actual results to differ materially are the following: our ability to successfully complete clinical trials for Zerenex; our ability to meet anticipated development timelines for Zerenex due to recruitment, clinical trial results, manufacturing capabilities or other factors; our ability to replicate in our planned Phase 3 clinical program the efficacy and safety of Zerenex observed in the previous Phase 2 and the Open Label Extension clinical trials, and the effects on IV iron and EPO use observed in these previous clinical trials; and other risk factors identified from time to time in our reports filed with the Securities and Exchange Commission. Any forward-looking statements set forth in this press release speak only as of the date of this press release. We do not intend to update any of these forward-looking statements to reflect events or circumstances that oc
'/>"/>

SOURCE Keryx Biopharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Keryx Reports Results of Open Label Extension Study Examining Long-Term Use of Zerenex, an Iron-Based Phosphate Binder, for the Treatment of Hyperphosphatemia
2. Keryx Biopharmaceuticals Phase 2 Data of KRX-0401 (Perifosine) in the Treatment of Advanced Metastatic Renal Cell Cancer Selected for Oral Presentation at the Eighth International Kidney Cancer Symposium
3. Keryx Biopharmaceuticals, Inc. Commences Phase 1 Study of KRX-0401 (Perifosine) in Recurrent Pediatric Solid Tumors at Memorial Sloan-Kettering Cancer Center
4. Keryx Biopharmaceuticals Announces Positive Data from a Randomized, Multi-Center, Placebo-Controlled, Phase 2 Combination Study of KRX-0401 (Perifosine) in the Treatment of Advanced Metastatic Colon Cancer
5. Keryx Biopharmaceuticals Reports Positive Data from a Randomized, Multi-Center, Placebo-Controlled, Phase 2 Combination Study of KRX-0401 (Perifosine) in the Treatment of Advanced Metastatic Colon Cancer
6. Keryx Biopharmaceuticals Reports Single Agent Phase 2 Data of KRX-0401 (Perifosine) Further Demonstrating KRX-0401s Activity in the Treatment of Advanced Metastatic Renal Cell Cancer
7. Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data on KRX-0401 (Perifosine) in Combination with Bortezomib (+/- Dexamethasone) at the 12th International Multiple Myeloma Meeting
8. Keryx Biopharmaceuticals, Inc. Reports Phase 1/2 Data on KRX-0401 (Perifosine) at 50th Annual Meeting of American Society of Hematology
9. Keryx Biopharmaceuticals, Inc. Announces Phase 2 Results on KRX-0401 (Perifosine) in Patients with Relapsed/Refractory Waldenstroms Macroglobulinemia at the 44th Annual Meeting of the American Society of Clinical Oncology
10. Keryx Biopharmaceuticals, Inc. Announces Poster Presentation Highlighting Observed Clinical Activity of KRX-0401 (Perifosine) at the American Society of Clinical Oncology Meeting in Chicago, Illinois
11. Keryx Biopharmaceuticals Announces Termination of SUN-MACRO Phase 4 Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... Mass. , Aug. 27, 2014 Decision ... that characterized the Memphis health ... way to clinical integration, with rivals Methodist Le Bonheur ... respective physician groups to coordinate patient care. In addition, ... which has the most health plan enrollment in the ...
(Date:8/27/2014)... 2014 ResearchMoz presents this most ... Market Outlook to 2020. New report, "United States Laparoscopes ... the United States Laparoscopes market . The report ... units) and average prices (in US dollars) within market ... Tip Video Laparoscopes), Robotic Surgical Systems and Rigid Tip ...
(Date:8/27/2014)... An experimental drug designed to help regulate the ... for anemia of inflammation, according to results from the first ... in Blood , the Journal of the ... Anemia is a condition that occurs when red blood cells ... an individual has anemia, the body does not get enough ...
Breaking Medicine Technology:Memphis-area Health Systems Turn Attention to Clinical Integration 2United States Laparoscopes Market Outlook, Analysis, Size, Share, Growth, Trends And Forecast 2020 2United States Laparoscopes Market Outlook, Analysis, Size, Share, Growth, Trends And Forecast 2020 3United States Laparoscopes Market Outlook, Analysis, Size, Share, Growth, Trends And Forecast 2020 4United States Laparoscopes Market Outlook, Analysis, Size, Share, Growth, Trends And Forecast 2020 5Drug Represents First Potential Treatment for Common Anemia 2Drug Represents First Potential Treatment for Common Anemia 3
... N.C., Nov. 16, 2011 Savvy executives in ... to remain competitive in today,s volatile healthcare environment. ... a business case for increased resources, justify costs, ... support pharmaceutical vice presidents, directors, and managers tasked ...
... Patient Safety Technologies, Inc. (the "Company", OTCBB: PSTX, ... quarter of 2011 ended September 30th, 2011. ... quarter of 2011, the number of institutions using the ... lost no customers.  This compares to approximately 57 institutions ...
Cached Medicine Technology:Pharmaceutical Investment & Cost Benchmarks Accessed Quickly Through Best Practices, LLC's New Database Search Function 2Patient Safety Technologies Reports Third Quarter 2011 Results 2Patient Safety Technologies Reports Third Quarter 2011 Results 3Patient Safety Technologies Reports Third Quarter 2011 Results 4Patient Safety Technologies Reports Third Quarter 2011 Results 5Patient Safety Technologies Reports Third Quarter 2011 Results 6Patient Safety Technologies Reports Third Quarter 2011 Results 7
(Date:8/28/2014)... 2014 The Foundation for Women’s ... in September by alerting women to the link between ... the symptoms of endometrial cancer. , Endometrial cancer ... most common cancer. More than 52,600 will learn of ... for women with weight management challenges to know the ...
(Date:8/28/2014)... PA (PRWEB) August 28, 2014 ... one of its clients, an inventor from California, has ... abdominal area. This invention is patented. , The “Abdominal ... to minimize the risk of injuries from physical activity ... due to surgery or muscular atrophy. Ideal for ...
(Date:8/28/2014)... (PRWEB) August 28, 2014 Altec ... and workflow solutions, announced today that they have ... the SoCal Chapter of the International Association of ... Services. IAMCP was founded in 1994, providing Microsoft ... and the IT community at large while facilitating ...
(Date:8/28/2014)... Dr. Stewart Shofner of ... the summer that recently headed off to college. According ... over 22 million students will attend college or university ... time attending classes, studying for exams, participate in sports ... eye problems. , Dr. Stewart Shofner shares five ...
(Date:8/28/2014)... Lauderdale, Fla. (PRWEB) August 28, 2014 A ... about the possibility of suicide contagion as a result of ... headlines, there is an increased risk of ‘copycat suicides’ among ... that the focus should not be on what happened—the suicide ... that lead to suicide. , “Suicide is a tragedy ...
Breaking Medicine News(10 mins):Health News:Foundation for Women's Cancer Alerts Women to Link Between Obesity and Endometrial Cancer 2Health News:InventHelp® Client Patents “Abdominal Swimming Support” – Invention Could Serve as an Alternative Flotation Device 2Health News:Altec and Bond Consulting Services Receive Award from the International Association of Microsoft Channel Partners SoCal Chapter 2Health News:Altec and Bond Consulting Services Receive Award from the International Association of Microsoft Channel Partners SoCal Chapter 3Health News:Renowned Eye Surgeon Dr. Shofner Shares Five Important Vision Tips For College Students 2Health News:Renowned Eye Surgeon Dr. Shofner Shares Five Important Vision Tips For College Students 3Health News:Sylvia Brafman Mental Health Center Warns of Suicide Contagion Following Robin Williams’ Death 2
... discovered by researchers at the University of North Carolina at ... forms of pancreatic cancer//, according to a study by an ... discovered six years ago by Dr. Carol Otey and her ... Brigham and Women’s Hospital in Boston. Otey has shown that ...
... An index comprising of the basic symptoms associated with ... its early stages, according to a new study.// This ... screening tool. ,The details of this study ... CANCER (http://www.interscience.wiley.com/cancer-newsroom), a peer-reviewed journal of the American Cancer ...
... H5N1 Outbreak as the Flu killed thousands of quails at a ... quails died over the weekend at a farm in Kimje, 262 ... have begun to cull the quails in the farm of the ... the third case since November 23 starting with an first outbreak ...
... Queensland (Australia) government has decided //to toughen its laws on ... cars carrying children. This comes in the wake of ... age, dies every 18 days, when exposed to cigarette smoke. ... of Queenslanders Report, 2006, made these comments. ,A ...
... Washington University School of Medicine have found out that successful ... dependence in many smokers. This study published in the December ... to look at smoking relapse among people who were "forced" ... has found that close to half of 154 smokers who ...
... face any kind of unforeseen pandemic, the province of Ontario ... disease control.// The officials, plan to form the centre on ... situated in Atlanta, U.S. ,Canadian media, quoting government ... intends to initiate proceedings to frame legislation, on the 12th ...
Cached Medicine News:Health News:Gene Discovered by Researchers Tied to Pancreatic Cancer 2Health News:A Basic Symptom Index For Early Detection Of Ovarian Cancer 2Health News:Lung Cancer Surgeries Doesn’t Help Breaking Nicotine Dependence in Smoker 2Health News:Lung Cancer Surgeries Doesn’t Help Breaking Nicotine Dependence in Smoker 3
... aqueous samples of moderate viscosity and density. Proven ergonomic design reduces hand ... Volume Range (ul) ... 2~5 Imprecision(%) ... 0.01 ...
... offers improved ergonomics for today's exacting ... grippy finger rest and the large ... efficiency. Finnpipette Digitals also feature soft-touch ... (pat. pend.) and super blow-out for ...
... Ultra is a fully adjustable, air-displacement pipette ... is the latest member of the Pipetman ... robustness, accuracy, and precision. We also added ... from our customers. Eight models cover the ...
Developed specifically for the 5000/5500 ultrasound consoles....
Medicine Products: